Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis

Background: Dabigatran is a univalent low-molecular-weight direct thrombin inhibitor which was developed as an alternative to vitamin K antagonists (VKAs). However, the safety of dabigatran remains controversial so far. In this study, we aimed to compare the risk of bleeding, fatal adverse events, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ya, Yao, Zhihao, Zhu, Linjie, Tang, Yong, Chen, Jie, Wu, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901998/
https://www.ncbi.nlm.nih.gov/pubmed/33633574
http://dx.doi.org/10.3389/fphar.2021.626063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901998/
https://www.ncbi.nlm.nih.gov/pubmed/33633574
http://dx.doi.org/10.3389/fphar.2021.626063

Ejemplares similares